Healthcare undertaking fundraising soared to $seventeen billion in 2020, a fifty seven% raise over 2019’s record, according to Silicon Valley Financial institution. Financial investment in undertaking-backed companies also rose to a new significant of $51 billion.
SVB’s 10th once-a-year Healthcare Investments and Exits Report, introduced Thursday at SVB’s Innovate Future virtual summit, analyzes and predicts traits for international undertaking money fundraising, investing and exits that shape the biopharma, healthtech, diagnostics/equipment and clinical product sectors.
What is THE Effect
Solid IPO atmosphere and sturdy private merger and acquisition activity propelled U.S. health care undertaking fundraising to a fourth-consecutive record year to $17B. The 3rd quarter of 2020 set a significant-drinking water financial investment mark of $fifteen billion, the biggest health care financial investment quarter at any time recorded. Every sector — biopharma, healthtech, dx/equipment and product — professional record financial investment.
IPOs in all sectors set or tied record figures. Submit-IPO efficiency for undertaking-backed 2020 health care IPOs has been outstanding, with normal efficiency of +one hundred%.
Record biopharma financial investment was led by massive mezzanine rounds that immediately transitioned to IPOs. 30-a few biopharma companies closed mezzanine rounds in 2020 and went general public in the exact same year. The time in between mezzanine spherical and IPO averaged just a few months.
The quantity of healthtech specials surpassed biopharma for the initial time at any time (614 vs. 570), but biopharma financial investment ranked greatest with $24.five billion invested. Biopharma and dx/equipment each individual noticed multiple $one billion-as well as private M&A in 2020, main equally sectors to record returns for the year.
Healthtech companies achieved a market place cap of $9.8 billion at IPO. Compared to 2019’s full of $five.7 billion, this year’s course of IPOs were being nearly 2 times as useful at IPO.
Machine M&A was down in 2020, but the sector has noticed sustained IPO activity and record write-up-IPO efficiency Submit-IPO efficiency for the course of 2020 achieved a health care greatest of +150%.
In phrases of outlook for the coming year, SVB anticipates steady biopharma financial investment in Collection A and afterwards-phase mezzanine financing, slightly down below 2020’s record figures. Meanwhile, healthtech financial investment will keep on being potent as virtual and hybrid care designs see ongoing development, much more undertaking-backed healthtech companies will develop to offer alternate care.
Dx/equipment could reach record financial investment once again in 2021. Deal figures will very likely slide, but the pounds invested should really be in line with 2020 volumes.
THE Larger Pattern
2020 also noticed an raise in electronic health and fitness funding. Mercom Funds Group this 7 days introduced its tally: $fourteen.8 billion in equity raised across 637 specials, as well as $six.8 billion in personal debt and general public market place financing across 26 specials.
These represent a respective 66% and 278% raise over the firm’s depend for 2019. In full, one,694 various investors took element in these specials, and the agency tracked a full of 184 mergers and acquisitions all through the past year, a slight raise over the 169 transactions of 2019.
In just the fourth quarter of 2020, there were being 139 equity funding specials totaling $four.five billion, a a hundred sixty five% raise over This fall 2019.
E mail the author: [email protected]